Literature DB >> 19133249

Upregulation and secretion of macrophage inhibitory cytokine-1 (MIC-1) in gastric cancers.

Kyoung Eun Baek1, Suk Ran Yoon, Jong-Tae Kim, Kwang Soo Kim, Seong Ho Kang, Young Yang, Jong-Seok Lim, Inpyo Choi, Myoung Soo Nam, Michung Yoon, Hee Gu Lee.   

Abstract

BACKGROUND: Macrophage inhibitory cytokine-1 (MIC-1), a distant member of the transforming growth factor (TGF)-beta superfamily, has been reported to be upregulated and secreted from several cancers. We examined MIC-1 expression and secretion in gastric cancers.
METHODS: MIC-1 mRNA and protein levels in cancer tissues and cell lines were analyzed by RT-PCR and Western blot. MIC-1 expression in cancer tissues and its secretion in serum were analyzed using immunohistochemistry and ELISA.
RESULTS: MIC-1 was significantly upregulated in gastric cancer tissues and cell lines. MIC-1 was secreted from gastric SNU620 cells and its levels in the serum of cancer patients were 10-fold higher than those of healthy controls. In addition, the staining of MIC-1 expression was strongly increased in metastatic gastric cancers.
CONCLUSIONS: MIC-1 was obviously overexpressed in gastric cancers and MIC-1 secretion into blood may be useful for the prediction of gastric cancer progression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19133249     DOI: 10.1016/j.cca.2008.12.008

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  18 in total

1.  Neurobehavioral Alterations in a Genetic Murine Model of Feingold Syndrome 2.

Authors:  E Fiori; L Babicola; D Andolina; A Coassin; T Pascucci; L Patella; Y-C Han; A Ventura; R Ventura
Journal:  Behav Genet       Date:  2015-05-31       Impact factor: 2.805

Review 2.  The diverse roles of nonsteroidal anti-inflammatory drug activated gene (NAG-1/GDF15) in cancer.

Authors:  Xingya Wang; Seung Joon Baek; Thomas E Eling
Journal:  Biochem Pharmacol       Date:  2012-12-07       Impact factor: 5.858

3.  The effect of full length and mature NAG-1 protein overexpression on cytotoxicity of celecoxib, tamoxifen and doxorubicin in HT1080.

Authors:  S Barezi; N Fahham; M Seyedabadi; S N Ostad; M H Ghahremani
Journal:  Daru       Date:  2010       Impact factor: 3.117

4.  Macrophage inhibitory cytokine-1 (MIC-1/GDF15) gene deletion promotes cancer growth in TRAMP prostate cancer prone mice.

Authors:  Yasmin Husaini; Glen P Lockwood; Trung V Nguyen; Vicky Wang-Wei Tsai; Mohammad G Mohammad; Pamela J Russell; David A Brown; Samuel N Breit
Journal:  PLoS One       Date:  2015-02-19       Impact factor: 3.240

5.  Combined Secretomics and Transcriptomics Revealed Cancer-Derived GDF15 is Involved in Diffuse-Type Gastric Cancer Progression and Fibroblast Activation.

Authors:  Takayuki Ishige; Motoi Nishimura; Mamoru Satoh; Mai Fujimoto; Masaki Fukuyo; Toshihisa Semba; Sayaka Kado; Sachio Tsuchida; Setsu Sawai; Kazuyuki Matsushita; Akira Togawa; Hisahiro Matsubara; Atsushi Kaneda; Fumio Nomura
Journal:  Sci Rep       Date:  2016-02-19       Impact factor: 4.379

6.  Plasma MIC-1 correlates with systemic inflammation but is not an independent determinant of nutritional status or survival in oesophago-gastric cancer.

Authors:  R J E Skipworth; D A C Deans; B H L Tan; K Sangster; S Paterson-Brown; D A Brown; M Hunter; S N Breit; J A Ross; K C H Fearon
Journal:  Br J Cancer       Date:  2010-01-26       Impact factor: 7.640

7.  Expression of the Body-Weight Signaling Players: GDF15, GFRAL and RET and their clinical relevance in Gastric Cancer.

Authors:  Karolina Buchholz; Paulina Antosik; Dariusz Grzanka; Maciej Gagat; Marta Smolińska; Alina Grzanka; Arkadiusz Gzil; Anna Kasperska; Anna Klimaszewska-Wiśniewska
Journal:  J Cancer       Date:  2021-06-04       Impact factor: 4.207

8.  Macrophage inhibitory cytokine-1 (MIC-1/GDF15) slows cancer development but increases metastases in TRAMP prostate cancer prone mice.

Authors:  Yasmin Husaini; Min Ru Qiu; Glen P Lockwood; Xu Wei Luo; Ping Shang; Tamara Kuffner; Vicky Wang-Wei Tsai; Lele Jiang; Pamela J Russell; David A Brown; Samuel N Breit
Journal:  PLoS One       Date:  2012-08-27       Impact factor: 3.240

9.  Variations in NAG-1 expression of human gastric carcinoma and normal gastric tissues.

Authors:  Gongli Yang; Qinhua Tan; Yongmei Xie; Bin Wei; Zhixin Chen; Chengwei Tang; Shengbao Li; Chunhui Wang
Journal:  Exp Ther Med       Date:  2013-10-24       Impact factor: 2.447

10.  Change of body weight and macrophage inhibitory cytokine-1 during chemotherapy in advanced gastric cancer: what is their clinical significance?

Authors:  Zhihao Lu; Li Yang; Jingwei Yu; Ming Lu; Xiaotian Zhang; Jian Li; Jun Zhou; Xicheng Wang; Jifang Gong; Jing Gao; Jie Li; Yan Li; Lin Shen
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.